跳至主要内容
临床试验/JPRN-UMIN000005079
JPRN-UMIN000005079已完成未知

A randomized double blind, placebo-controlled trial of efficacy and safety of Kamishoyosan in patients with climacteric symptoms - A randomized double blind, placebo-controlled trial of efficacy and safety of Kamishoyosan in patients with climacteric symptoms

Hirosaki University Graduate School of Medicine0 个研究点目标入组 200 人开始时间: 2011年3月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40years-old 至 60years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1) Patients with serious gastrointestinal weakness 2) Patients with anorexia, nausea and/or vomiting 3) Patients with psycho-neurologic disease (SDS>=60) 4) Patients with a history of drug allergy or hypersensitivity reaction to Kampo medicine 5) Patients with serious complications (hepatic, renal, cardiac diseases or malignancy tumor) 6) Patients who have been participated in other clinical trial within 4months before enrollment, or will participate in a clinical trial. 7) Patients who are assessed to be inappropriate for study participation by the investigator.

研究者

发起方
Hirosaki University Graduate School of Medicine

相似试验